Company news
OpSens Inc news in 2023
OpSens Inc's news releases, calls and decks from 2023, newest first.
Haemonetics completes acquisition of OpSens
December 12, 2023
OpSens receives final order for arrangement with haemonetics
December 8, 2023
OpSens' shareholders approve arrangement with haemonetics
December 1, 2023
OpSens obtains regulatory clearance of arrangement in the united states and Canada; regulatory approvals condition satisfied
November 28, 2023
OpSens announces fourth quarter and fiscal year 2023 Financial results
November 22, 2023
Independent proxy advisory firm ISS recommends shareholders vote "for" OpSens Inc. plan of arrangement with haemonetics corporation
November 13, 2023
OpSens receives interim order and files management information circular in connection with special meeting of shareholders
November 2, 2023
OpSens announces the positive clinical results from the SAFE-TAVI study with SavvyWire in europe
October 23, 2023
OpSens to Participate in the Transcatheter Cardiovascular Therapeutics Conference (TCT) in San Francisco October 23 - 26, 2023
October 17, 2023
OpSens signs definitive agreement for its acquisition by haemonetics
October 10, 2023
OpSens announces a third consecutive quarter of record revenues for third quarter fiscal 2023
July 13, 2023
OpSens to host third quarter fiscal year 2023 financial results conference call on Thursday July 13, 2023
July 6, 2023
OpSens announces inclusion of SavvyWire(tm) in complete TAVR study
May 10, 2023
OpSens Announces Participation in the 2023 Bloom Burton & Co. Healthcare Investor Conference
April 20, 2023
OpSens announces record revenue for second quarter fiscal 2023
April 13, 2023
OpSens announces completion of enrollment in SAFE-TAVI study with SavvyWire® in Europe
April 11, 2023
OpSens to host second quarter fiscal year 2023 financial results conference call on Thursday April 13, 2023
April 6, 2023
OpSens announces 1,000th SavvyWire procedure
April 5, 2023
OpSens appoints John Hannigan as Chief Financial Officer
March 27, 2023
OpSens awarded interventional specialty diagnostics agreement with Premier for SavvyWire(tm)
March 14, 2023
OpSens announces SavvyWire(tm) used during two live cases at CRT conference
February 28, 2023
OpSens Reports Annual General and Special Shareholders Meeting Voting Results
January 25, 2023
OpSens to participate in the lytham partners investor select conference
January 25, 2023
OpSens announces record first quarter fiscal 2023 Financial results
January 12, 2023
OpSens to host first quarter fiscal year 2023 financial results conference call on Thursday January 12, 2023
January 5, 2023
Decks in 2023
- Investor Presentation (November 2023)
Investor deck · 48 slides · Nov 22, 2023
- Investor Presentation (July 2023)
Investor deck · 48 slides · Jul 31, 2023
- Investor Presentation (July 2023)
Investor deck · 44 slides · Jul 31, 2023
- Investor Presentation (May 2023)
Investor deck · 48 slides · May 31, 2023
- Investor Presentation (2023)
Investor deck · 44 slides · Mar 1, 2023
- Investor Presentation (January 2023)
Investor deck · 44 slides · Jan 12, 2023
- Investor Presentation (January 2023)
Investor deck · 44 slides · Jan 12, 2023